Dr. Reddy's Laboratories
157 hedge funds and large institutions have $1.24B invested in Dr. Reddy's Laboratories in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 59 reducing their positions, and 22 closing their positions.
1.84% more ownership
Funds ownership: 78.7% → 80.54% (+1.8%)
0% more funds holding
Funds holding: 157 → 157 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
11% less capital invested
Capital invested by funds: $1.39B → $1.24B (-$153M)
20% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 59
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $1.27M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$22.4M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$10.6M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10.2M |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
+$8.86M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTP
Global Thematic Partners
New York
|
-$19.3M |
| 2 |
Lazard Asset Management
New York
|
-$10.3M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$7.55M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$7.11M |
| 5 |
Renaissance Technologies
New York
|
-$6.78M |
RDY Hedge Fund Activity: Q3 2016 in Review
157 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2016, worth a combined $1.24B — down 11% from $1.39B a quarter earlier.
Fund positioning in RDY was balanced in Q3 2016: 22 funds opened new positions, 22 closed out, 47 added to existing stakes and 59 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $22.4M. The largest seller was Global Thematic Partners, exiting entirely with an estimated $19.3M sold.
- 157 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $1.24B of Dr. Reddy's Laboratories stock for Q3 2016, down 11% quarter-over-quarter.
- 22 funds opened new Dr. Reddy's Laboratories positions in Q3 2016 and 22 closed out, a net change of 0 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2016 was Fisher Asset Management, an estimated $22.4M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2016 was Global Thematic Partners, an estimated $19.3M sold.
Based on aggregated 13F filings for Q3 2016.